Controller Area Network (CAN): License of Robert Bosch GmbH

C164CI

Revision History:

1998-02 Preliminary

Previous Releases:

04.97 (Advance Information)

Page

Subjects

3, 4

Alternate functions for P5 added.

25...30

Register Table updated.

32, 33

33, 34

Supply current specification improved.

33, 34

Idle supply current specification

39, 40

ADC specification improved.

49, 50

Description for READY removed.

–

“AC Characteristics Demultiplexed Bus” removed.

–

“AC Characteristics External Bus Arbitration” removed.

Edition 1998-02

Published by Siemens AG,

Bereich Halbleiter, Marketing-

Kommunikation, Balanstraße 73,

81541 München

All Rights Reserved.

Attention please!

As far as patents or other rights of third parties are concerned, liability is only assumed for components, not for applications, processes

and circuits implemented within components or assemblies.

The information describes the type of component and shall not be considered as assured characteristics.

Terms of delivery and rights to change design reserved.

For questions on technology, delivery and prices please contact the Semiconductor Group Offices in Germany or the Siemens Companies

and Representatives worldwide (see address list).

Due to technical requirements components may contain dangerous substances. For information on the types in question please contact

your nearest Siemens Office, Semiconductor Group.

Siemens AG is an approved CECC manufacturer.

Packing

Please use the recycling operators known to you. We can also help you – get in touch with your nearest sales office. By agreement we will

take packing material back, if it is sorted. You must bear the costs of transport.

For packing material that is returned to us unsorted or which we are not obliged to accept, we shall have to invoice you for any costs in-

curred.

Components used in life-support devices or systems must be expressly authorized for such purpose!

written approval of the Semiconductor Group of Siemens AG.

1 A critical component is a component used in a life-support device or system whose failure can reasonably be expected to cause the

failure of that life-support device or system, or to affect its safety or effectiveness of that device or system.

2 Life support devices or systems are intended (a) to be implanted in the human body, or (b) to support and/or maintain and sustain hu-

man life. If they fail, it is reasonable to assume that the health of the user may be endangered.